Nanomedicine News

RSS

ASM 2014: New Outcome Data from Studies Using Nanosphere's Verigene Infectious Disease Tests Presented

Nanosphere, Inc., a company enhancing medicine through targeted molecular diagnostics, today announced that new performance and clinical outcome data for three Verigene® multiplex infectious disease tests will be presented at the 114th General Meeting of the American Society for Microbiology (asm2014), to be held in Boston, Massachusetts on May 17 – 20, 2014.

19 May 2014

Novavax Reports One Year Follow-Up Data from RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial

Novavax, Inc. today announced follow-up data from its dose-ranging Phase 1 clinical trial of its respiratory syncytial virus (RSV) F-protein vaccine in 220 elderly adults (60 years of age and older, with a mean age of 68) that was initiated in October 2012.

From Novavax Inc. 13 May 2014

NPL to Develop Methodologies to Measure Radio-Biological Impact of Gold Nanoparticles

A new project at the National Physical Laboratory (NPL) will develop methodologies to measure the radio-biological impact of gold nanoparticles, when used in combination with ionising radiation for enhancing radiotherapy treatments and medical imaging.

13 May 2014

Lipid-Based Nanocapsule Drug Delivery Method Smuggles Drug into Cancer Cell before Release

Biomedical engineering researchers have developed an anti-cancer drug delivery method that essentially smuggles the drug into a cancer cell before triggering its release. The method can be likened to keeping a cancer-killing bomb and its detonator separate until they are inside a cancer cell, where they then combine to destroy the cell.

From North Carolina State University 12 May 2014

Researchers Target RNAi to Endothelial Cells Using Nanoparticles

RNA interference (RNAi), a technique that can turn off specific genes inside living cells, holds great potential for treating many diseases caused by malfunctioning genes. However, it has been difficult for scientists to find safe and effective ways to deliver gene-blocking RNA to the correct targets.

From Massachusetts Institute of Technology 12 May 2014

BIND Provides Update on BIND-014 Clinical Development Plan and Reports 1Q 2014 Financial Results

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today reported financial results for the first quarter ended March 31, 2014.

9 May 2014

Two Drugs Packaged in Liposome Nanoparticles Dramatically Shrink Tumors

MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage.

From Massachusetts Institute of Technology 9 May 2014

NanoViricides Synthesizes Drug Candidates for Testing Infection with MERS Corona Virus

NanoViricides, Inc. (the "Company") reported today that it has designed and synthesized novel nanoviricides® drug candidates in quantities sufficient for testing in animals infected with the MERS Corona Virus.

From NanoViricides, Inc 7 May 2014

Azaya Partners with University of Chicago to Study Taxotere Chemotherapy Agent

Azaya Therapeutics, Inc., a clinical-stage oncology company developing safer and more effective cancer treatments through its nanotechnology platform, announced a collaboration with the University of Chicago, in Chicago, Illinois.

7 May 2014

Capricor Executes Exclusive License Agreement for Exosome Intellectual Property with Cedars-Sinai Medical Center

Capricor Therapeutics, Inc., a biotechnology company focused on developing novel therapeutics for the treatment of cardiovascular diseases, today announced the execution of an Exclusive License Agreement with Cedars-Sinai Medical Center for intellectual property (IP) related to the development of exosomes.

7 May 2014

Nanomedicine News

ASM 2014: New Outcome Data from Studies Using Nanosphere's Verigene Infectious Disease Tests Presented

Novavax Reports One Year Follow-Up Data from RSV F-Protein Vaccine Candidate Phase 1 Elderly Trial

NPL to Develop Methodologies to Measure Radio-Biological Impact of Gold Nanoparticles

Lipid-Based Nanocapsule Drug Delivery Method Smuggles Drug into Cancer Cell before Release

Researchers Target RNAi to Endothelial Cells Using Nanoparticles

BIND Provides Update on BIND-014 Clinical Development Plan and Reports 1Q 2014 Financial Results

Two Drugs Packaged in Liposome Nanoparticles Dramatically Shrink Tumors

NanoViricides Synthesizes Drug Candidates for Testing Infection with MERS Corona Virus

Azaya Partners with University of Chicago to Study Taxotere Chemotherapy Agent

Capricor Executes Exclusive License Agreement for Exosome Intellectual Property with Cedars-Sinai Medical Center

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting